Kostas A. Triantaphyllopoulos

Prof. Dr. Kostas A. Triantaphyllopoulos

Biotechnology, Agricultural University of Athens, Athens, Attikí, Greece
orcid

Biography

Prof Kostas A. Triantaphyllopoulos (KT) received his PhD title by the Department of Biology of the University of Patras (1994) with honours (10/10). After his PhD, KT has pursued his career as a senior research fellow in the United Kingdom from 1994-2010. KT holds a position of Assistant Professor in Genetics, Department of Biotechnology of the Agricultural University of Athens, Greece. KT has won several stipends and awards in his career, from undergraduate to postgraduate & career awards such as, scholarship for postgraduate studies in Molecular Biology, competitive Greek scholarship for PhD studentship, Alternative Academic Discovery Initiative Award by Glaxo Smith Kline & Imperial College London & presentations. KT has 28 publications in high quality journals (>1300 citations) & at least 25 conference presentations, Nationally & Internationally. KT is a member of a few scientific societies such as, British Society for Immunology since 1996, London Chromatin Club, Greek scientific societies. His research interests involve the molecular mechanisms in health & disease, the genetics & epigenetic modulations under the environment. KT has longstanding experience in molecular techniques, animal models & involved in silico studies. KT teaches in the University, Molecular & Cellular Biology, Special Topics in Genetics, Heredity & Epigenetics, Pharmacogenomics, Personalized Medicine, Biotechnology & Immunobiology & participated in multidisciplinary postgraduate teaching program

Affiliations

Agricultural University of Athens

Athens, Attikí, Greece

Biotechnology

Honors and Awards

honor

Alternative Academic Discovery Initiative

Glaxo Smith Kline, Stevenage SG1 2NY, UK & Prof Ewa Paleolog (Imperial College London)

Money award in 2007-8, from the GSK Project Grant for exceptional research in collaboration with Imperial college London for "The In vitro target validation and in vivo efficacy of p38 MAP kinase inhibition in established chronic collagen-induced arthritis model: a pre-clinical study. The study suggests therapeutic potential for future use in Rheumatoid Arthritis if safe clinical dosing achieves adequate compound exposure.

honor

International Research Excellence and Citation Awards - Award Winners 2026

Tamil Nadu Agricultural University, Coimbatore, India

Best Review Article Award

Experience

No experience has been shared yet.